Conrad A. Messam

1.2k total citations
20 papers, 952 citations indexed

About

Conrad A. Messam is a scholar working on Molecular Biology, Developmental Neuroscience and Hematology. According to data from OpenAlex, Conrad A. Messam has authored 20 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Developmental Neuroscience and 5 papers in Hematology. Recurrent topics in Conrad A. Messam's work include Neurogenesis and neuroplasticity mechanisms (7 papers), Platelet Disorders and Treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Conrad A. Messam is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (7 papers), Platelet Disorders and Treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Conrad A. Messam collaborates with scholars based in United States, United Kingdom and Poland. Conrad A. Messam's co-authors include Eugene O. Major, Jean Hou, Randall N. Pittman, Hans‐Jörg Bühring, Wolfram Brugger, Wichard Vogel, Frank Grünebach, Lothar Kanz, June L. Biedler and Robert A. Ross and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Conrad A. Messam

20 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conrad A. Messam United States 14 397 230 213 200 170 20 952
Kam Sze Tsang Hong Kong 22 383 1.0× 324 1.4× 65 0.3× 225 1.1× 171 1.0× 50 1.1k
Peter J. Darlington Canada 18 447 1.1× 171 0.7× 173 0.8× 61 0.3× 215 1.3× 35 1.6k
Geralyn Annett United States 17 490 1.2× 442 1.9× 165 0.8× 196 1.0× 421 2.5× 22 1.7k
Violaine Harris United States 20 953 2.4× 289 1.3× 238 1.1× 83 0.4× 189 1.1× 31 1.5k
Mirko Nitsche Germany 14 257 0.6× 61 0.3× 144 0.7× 228 1.1× 195 1.1× 41 1.4k
Anaïck Moisan France 19 418 1.1× 418 1.8× 134 0.6× 156 0.8× 87 0.5× 33 1.2k
Yelena S. Tarasova United States 13 732 1.8× 137 0.6× 139 0.7× 188 0.9× 135 0.8× 26 1.1k
Lucia Zanotti Italy 12 503 1.3× 534 2.3× 567 2.7× 152 0.8× 112 0.7× 20 1.3k
Luís I. Sánchez-Abarca Spain 14 379 1.0× 248 1.1× 58 0.3× 100 0.5× 168 1.0× 19 1.0k
Khang‐Loon Ho United States 21 397 1.0× 333 1.4× 342 1.6× 217 1.1× 83 0.5× 31 1.8k

Countries citing papers authored by Conrad A. Messam

Since Specialization
Citations

This map shows the geographic impact of Conrad A. Messam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad A. Messam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad A. Messam more than expected).

Fields of papers citing papers by Conrad A. Messam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad A. Messam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad A. Messam. The network helps show where Conrad A. Messam may publish in the future.

Co-authorship network of co-authors of Conrad A. Messam

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad A. Messam. A scholar is included among the top collaborators of Conrad A. Messam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad A. Messam. Conrad A. Messam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winer, Eric S., Howard Safran, Bogusława Karaszewska, et al.. (2014). Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I study. Cancer Medicine. 4(1). 16–26. 39 indexed citations
3.
Erickson‐Miller, Connie L., Kodandaram Pillarisetti, David J. Figueroa, et al.. (2012). Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors. BMC Cancer. 12(1). 405–405. 15 indexed citations
4.
Mittelman, Moshe, Sarit Assouline, Evangelos Briasoulis, et al.. (2012). Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study. Blood. 120(21). 3822–3822. 8 indexed citations
6.
Erickson‐Miller, Connie L., Kodandaram Pillarisetti, Katherine L. Baker-Neblett, et al.. (2010). Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors. Journal of Oncology. 2010. 1–8. 9 indexed citations
7.
Ding, Shinghua, Conrad A. Messam, Peiying Li, et al.. (2006). Murine Brain Progenitor Cells have the Ability to Differentiate into Functional Neurons and Integrate into the CNS. Cell Transplantation. 15(8-9). 699–710. 8 indexed citations
8.
Tseng, Henry C., Stephan Rüegg, Margaret Maronski, et al.. (2005). Injuring neurons induces neuronal differentiation in a population of hippocampal precursor cells in culture. Neurobiology of Disease. 22(1). 88–97. 9 indexed citations
9.
Messam, Conrad A., et al.. (2004). Nestin Is a Potential Mediator of Malignancy in Human Neuroblastoma Cells. Journal of Biological Chemistry. 279(27). 27994–27999. 82 indexed citations
10.
Messam, Conrad A., Jean Hou, Richard M. Gronostajski, & Eugene O. Major. (2003). Lineage pathway of human brain progenitor cells identified by JC virus susceptability. Annals of Neurology. 53(5). 636–646. 56 indexed citations
11.
Humphrey, Rohan K., Nathan Bucay, Gillian M. Beattie, et al.. (2003). Characterization and Isolation of Promoter-Defined Nestin-Positive Cells from the Human Fetal Pancreas. Diabetes. 52(10). 2519–2525. 64 indexed citations
12.
Vogel, Wichard, Frank Grünebach, Conrad A. Messam, et al.. (2003). Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells.. PubMed. 88(2). 126–33. 187 indexed citations
13.
Kim, Hyung-Seok, et al.. (2002). Comparative Evaluation of Angiogenesis in Gastric Adenocarcinoma by Nestin and CD34. Applied immunohistochemistry & molecular morphology. 10(2). 121–127. 36 indexed citations
14.
Messam, Conrad A., Jean Hou, Joan W. Berman, & Eugene O. Major. (2002). Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells. Developmental Brain Research. 134(1-2). 87–92. 52 indexed citations
15.
Gu, Huaiyu, et al.. (2002). Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Research. 943(2). 174–180. 48 indexed citations
16.
Vanderwinden, Jean‐Marie, et al.. (2002). Distribution of the intermediate filament nestin in the muscularis propria of the human gastrointestinal tract. Cell and Tissue Research. 309(2). 261–268. 44 indexed citations
17.
Kim, Hyung-Seok, et al.. (2002). . Applied Immunohistochemistry. 10(2). 121–127. 4 indexed citations
18.
Messam, Conrad A., Jean Hou, & Eugene O. Major. (2000). Coexpression of Nestin in Neural and Glial Cells in the Developing Human CNS Defined by a Human-Specific Anti-nestin Antibody. Experimental Neurology. 161(2). 585–596. 161 indexed citations
19.
Messam, Conrad A. & Randall N. Pittman. (1998). Asynchrony and Commitment to Die during Apoptosis. Experimental Cell Research. 238(2). 389–398. 78 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026